LOIS M RAMONDETTA to Neurofibromin 1
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Neurofibromin 1.
Connection Strength
0.045
-
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Invest New Drugs. 2021 06; 39(3):829-835.
Score: 0.045